Evidence map›Paper›PMID 32516405›Full record

ArticleInvestigative ophthalmology & visual science2020

Cell Line Authentication in Vision Research and Beyond: A Tale Retold.

Jeremy Peavey, Goldis Malek

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeremy Peavey,.
Goldis Malek,.

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
Novel signaling pathways regulated by the liver x receptor in age-related macular degenerationR01EY027802 · NEI · DUKE UNIVERSITY · PI MALEK, GOLDIS · 2018 to 2021
$1.9M
Regulation of inflammation and lipid homeostasis by the aryl hydrocarbon receptor in age-related macular degenerationR01EY028160 · NEI · DUKE UNIVERSITY · PI MALEK, GOLDIS · 2018 to 2021
$1.8M
NEI NIH HHS P30 EY005722NEI NIH HHS R01 EY027802NEI NIH HHS R01 EY028160
6 · The paper itself

Abstract

We live in an age where new technologies, and organizations involved in the distribution of biological materials, such as cell culture lines, have eased accessibility to a variety of in vitro models, developed, and/or harvested from different sources. In translational and basic ophthalmology research, in vitro assays are an essential component to discovery and preclinical studies. It is, therefore, of utmost importance for vision researchers to be cognizant of the risks surrounding the use of newly developed cell culture models and how scientific integrity could be impacted when standard operating procedures are not followed for cell line validation and identification. Herein, we discuss authentication challenges we faced when we obtained a newly marketed human choroidal endothelial cell line for vision research, and outline our process of validating and characterizing primary human choroidal endothelial cell lines in the laboratory.

Indexed as

Cell Line AuthenticationBiomarkersBiomedical ResearchCell Culture TechniquesCell LineChoroidEndothelial CellsFlow CytometryGenetic LociHumansOphthalmologyReal-Time Polymerase Chain ReactionBiomarkers

Identifiers

PMID32516405
PMCPMC7415283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.